Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Phoenix, Arizona, United States of America.
Division of Dermatology, Department of Medicine, Mayo Clinic, Phoenix Arizona, United States of America.
PLoS One. 2018 Nov 21;13(11):e0207819. doi: 10.1371/journal.pone.0207819. eCollection 2018.
The goal is to determine the delays and reduced rates of kidney transplant (KTx) for the Indigenous Americans and variables predictive of these outcomes at a large single transplant center.
300 Indigenous Americans and 300 non-Hispanic white American patients presenting for KTx evaluation from 2012-2016 were studied.
Compared to whites, the Indigenous Americans had the following: more diabetes, dialysis, physical limitation and worse socioeconomic characteristics(p<0.01); median difference of 20 day delay from referral to KTx evaluation, 17 day delay from approval to UNOS listing and 126.5 longer delay on the waitlist compared to whites(p<0.001). Of the Indigenous Americans listed, more died, were removed, or were still waiting than transplanted compared to whites (p<0.001). Variables predictive of delay from referral to transplant evaluation included: Indigenous race, distance from transplant center, coronary artery disease, and time on dialysis (p<0.05). Cumulative incidence of waitlisting and KTx was lower for Indigenous Americans (p<0.0001). Independent predictors of decreased likelihood of waitlisting included age, peripheral vascular disease, no caregiver, physical limitation, and illegal drug use history (p<0.05). Variables predictive of lower likelihood of KTx included Indigenous race, percentage of time inactive on the waitlist, no caregiver, and O blood type.
Among patients referred and evaluated for KTx, the Indigenous American race was independently associated with significant delays in the KTx process after accounting for co-morbid and socioeconomic factors. Cardiovascular morbidity and physical limitation were identified as important determinants of delay and decreased likelihood of waitlisting. Further quantitative and qualitative work is needed to identify and intervene on modifiable barriers to improve access to KTx for the Indigenous Americans.
本研究旨在确定在一家大型单中心中,美国原住民接受肾移植(KTx)的延迟和降低的比例,以及预测这些结果的变量。
研究纳入了 2012 年至 2016 年期间在该移植中心接受 KTx 评估的 300 名美国原住民和 300 名非西班牙裔白人患者。
与白人相比,美国原住民患者具有以下特点:更多的糖尿病、透析、身体限制和较差的社会经济特征(p<0.01);从转诊到 KTx 评估的中位数延迟为 20 天,从批准到 UNOS 列入名单的中位数延迟为 17 天,等待名单上的中位数延迟为 126.5 天(p<0.001)。与白人相比,列入名单的美国原住民患者中,死亡、被移除或仍在等待移植的患者比例高于接受移植的患者(p<0.001)。从转诊到移植评估的延迟的预测变量包括:美国原住民种族、与移植中心的距离、冠状动脉疾病和透析时间(p<0.05)。美国原住民的等待名单和 KTx 的累积发生率较低(p<0.0001)。等待名单和 KTx 可能性降低的独立预测因素包括年龄、外周血管疾病、无照顾者、身体限制和非法药物使用史(p<0.05)。预测 KTx 可能性降低的变量包括美国原住民种族、等待名单上不活跃的时间百分比、无照顾者和 O 血型。
在接受 KTx 转诊和评估的患者中,在考虑合并症和社会经济因素后,美国原住民种族与 KTx 过程中的显著延迟独立相关。心血管发病率和身体限制被确定为延迟和等待名单可能性降低的重要决定因素。需要进一步进行定量和定性研究,以确定和干预可改变的障碍,以改善美国原住民获得 KTx 的机会。